Deciphera Pharmaceuticals Inc (DCPH.OQ)
DCPH.OQ on NASDAQ Stock Exchange Global Select Market
23.45USD
18 Apr 2019
23.45USD
18 Apr 2019
Change (% chg)
$0.48 (+2.09%)
$0.48 (+2.09%)
Prev Close
$22.97
$22.97
Open
$22.95
$22.95
Day's High
$23.52
$23.52
Day's Low
$22.27
$22.27
Volume
72,641
72,641
Avg. Vol
74,729
74,729
52-wk High
$45.61
$45.61
52-wk Low
$18.56
$18.56
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Dec '18 | 0.00 | -0.857 |
| Sep '18 | 0.00 | -0.649 | |
| Jun '18 | 0.00 | -0.646 | |
| Mar '18 | 0.00 | -0.657 | |
| FY 2017 | Dec '17 | 0.00 | -0.649 |
| Sep '17 | 0.00 | -0.392 | |
| Jun '17 | 0.00 | -0.346 | |
| Mar '17 | 0.00 | -0.251 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-19 | 9 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Sep-19 | 9 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Dec-19 | 10 | 10.00 | 100.00 | 0.00 | 15.00 |
| Year Ending Dec-20 | 10 | 17.25 | 48.90 | 0.70 | 28.64 |
| Earnings (per share) | |||||
| Quarter Ending Jun-19 | 10 | -0.87 | -0.66 | -1.00 | -0.82 |
| Quarter Ending Sep-19 | 10 | -0.88 | -0.64 | -1.08 | -0.85 |
| Year Ending Dec-19 | 11 | -3.22 | -1.51 | -4.17 | -2.37 |
| Year Ending Dec-20 | 10 | -3.54 | -2.60 | -4.46 | -2.52 |
| LT Growth Rate (%) | 1 | 21.00 | 21.00 | 21.00 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 69.30 | 32.55 | |
| P/E High - Last 5 Yrs. | -- | 147.69 | 48.10 | |
| P/E Low - Last 5 Yrs. | -- | 47.94 | 23.42 | |
| Beta | -- | 1.08 | 0.87 | |
| Price to Sales (TTM) | -- | 49.51 | 8.39 | |
| Price to Book (MRQ) | -- | 10.13 | 5.27 | |
| Price to Tangible Book (MRQ) | 8.04 | 13.74 | 6.74 | |
| Price to Cash Flow (TTM) | -- | 56.16 | 24.12 | |
| % Owned Institutions | -- | 3.71 | 1.65 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.12 | 1.35 | |
| Dividend Yield - 5 Year Avg | -- | 0.09 | 1.37 | |
| Dividend 5 Year Growth Rate | -- | 0.78 | 4.70 | |
| Payout Ratio(TTM) | -- | 7.02 | 39.61 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 206.06 | 13.46 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -- | 49.00 | 8.04 | |
| Sales - 5 Yr. Growth Rate | -- | 22.77 | 10.85 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -79.11 | 75.31 | 47.73 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -- | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 11.97 | 10.46 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 9.11 | 14.68 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.24 | 2.18 |
| Current Ratio (MRQ) | 11.53 | 3.57 | 2.98 |
| LT Debt to Equity (MRQ) | 1.59 | 18.63 | 11.32 |
| Total Debt to Equity (MRQ) | 1.80 | 31.30 | 16.01 |
| Interest Coverage (TTM) | -- | -43.11 | 28.44 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 56.27 | 52.41 | |
| Gross Margin - 5 Yr. Avg. | -- | 60.50 | 50.39 | |
| EBITD Margin (TTM) | -- | -- | -- | |
| EBITD - 5 Yr. Avg | -- | -110.67 | 12.41 | |
| Operating Margin (TTM) | -- | -184.95 | 5.77 | |
| Operating Margin - 5 Yr. Avg. | -- | -127.15 | 8.01 | |
| Pre-Tax Margin (TTM) | -- | -175.66 | 4.79 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -132.94 | 8.29 | |
| Net Profit Margin (TTM) | -- | -182.37 | 1.52 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -137.34 | 4.70 | |
| Effective Tax Rate (TTM) | -- | 22.47 | 22.13 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 15.50 | 22.58 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 7,653,406 | 820,412,550 | |
| Net Income/Employee (TTM) | -- | 513,605 | 92,866,182 | |
| Receivable Turnover (TTM) | -- | 6.28 | 5.82 | |
| Inventory Turnover (TTM) | -- | 1.89 | 3.41 | |
| Asset Turnover (TTM) | -- | 0.32 | 0.90 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -- | 6.38 | 10.60 | |
| Return on Assets - 5 Yr. Avg. | -- | 5.47 | 11.78 | |
| Return on Investment (TTM) | -- | 8.91 | 13.83 | |
| Return on Investment - 5 Yr. Avg. | -- | 6.79 | 15.32 | |
| Return on Equity (TTM) | -- | 10.06 | 15.25 | |
| Return on Equity - 5 Yr. Avg. | -- | 8.32 | 16.41 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -- | -- | -- |
| EPS (TTM) % | -30.90 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Deciphera Pharmaceuticals Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -- | -- | -- | 99 |
| 13 Week | -- | -- | -- | 95 |
| 26 Week | -- | -- | -- | 97 |
| 52 Week | -- | -- | -- | 69 |
| YTD | -- | -- | -- | 72 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 58.36% |
| # of Holders: | 113 |
| Total Shares Held: | 22,288,641 |
| 3 Mo. Net Change: | -26,697 |
| # New Positions: | 3 |
| # Closed Positions: | 1 |
| # Increased Positions: | 7 |
| # Reduced Positions: | 6 |
| # Net Buyers: | 1 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.